View Author
patient cancer death £ ow rate prostate pressure lymph-node dissection prostate cancer study group cause lymph-node dissection statistic screening bladder classi strategy ficial statistics trial statistics netherlands bladder pressure nephrectomy netherland ¯ ow rate non-obstructed ¢cation ficial survival rotterdam lymph nodes lymph screening arm speci ficity cell carcinoma table catheter classi ¢ed control arm european prostate cancer death prostate cancer deaths metastase carcinoma obstruction panel mortality disease lymph-node metastases number lymph node dissection speci measurement pext.max lymphadenectomy value review result tumor control death certi ficates prostate cancer mortality classi ¢cation urology method isovolumetric bladder pressure 13.8 ml /s bladder outlet obstruction voiding ficity van mastrigt r prostate cancer diagnosis entry sensitivity rotterdam section non-obstructed patients erspc mastrigt randomized analysis
3 Most Recent Publications
|
Blinded and uniform causes of death verification in cancer screening: A major influence on the outcome of a prostate cancer screening trial?
(Article)
Otto, S.J. Leeuwen, P.J. van Hoekstra, J.W. Merckelbach, J.W. Blom, J.H.M. Schröder, F.H. Roobol, M.J. Koning, H.J. de |
2010-11-01
|
|
Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881
(Article)
Blom, J.H.M. Poppel, H. van Maréchal, J.M. Jacqmin, D. Schröder, F.H. Prijck, L. de Sylvester, R. |
2009-01-01
|
|
Development of a non-invasive strategy to classify bladder outlet obstruction in male patients with LUTS
(Article)
Pel, J.J.M. Bosch, J.L.H.R. Blom, J.H.M. Lycklama a Nijeholt, A.A.B. Mastrigt, R. van |
2002-02-22
|
